← Back to Analyst Consensus 
GBIO Buy
Generation Bio Co.
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 3, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Dec 16, 2025 | Wedbush | upgrade | Neutral → Outperform | $5.5 | 58% |
| Dec 16, 2025 | Jefferies | downgrade | Buy → Hold | $5 | 52% |
| Aug 18, 2025 | Canaccord Genuity | maintain | Buy → Buy | $10 | 48% |
| Aug 13, 2025 | Needham | reiterate | Buy → Buy | $15 | 50% |
| Aug 13, 2025 | Wedbush | downgrade | Outperform → Neutral | $7 | 58% |
| May 8, 2025 | Needham | reiterate | Buy → Buy | $8 | 50% |
| Apr 10, 2025 | Needham | reiterate | Buy → Buy | $8 | 50% |
| Mar 17, 2025 | Canaccord Genuity | maintain | Buy → Buy | $9 | 48% |
| Mar 14, 2025 | Citizens Capital Markets | reiterate | Market Perform → Market Perform | $0 | 49% |
| Mar 14, 2025 | Needham | reiterate | Buy → Buy | $8 | 50% |
| Jan 8, 2025 | Needham | maintain | Buy → Buy | $8 | 50% |
| Oct 23, 2024 | Needham | reiterate | Buy → Buy | $10 | 50% |
| Aug 8, 2024 | Wedbush | reiterate | Outperform → Outperform | $5 | 58% |
| Aug 8, 2024 | Needham | reiterate | Buy → Buy | $10 | 50% |
| May 14, 2024 | Needham | reiterate | Buy → Buy | $10 | 50% |
| May 14, 2024 | Wedbush | reiterate | Outperform → Outperform | $5 | 58% |
| Apr 10, 2024 | Needham | reiterate | Buy → Buy | $10 | 50% |
| Mar 7, 2024 | Wedbush | reiterate | Outperform → Outperform | $5 | 58% |
| Mar 7, 2024 | Needham | maintain | Buy → Buy | $10 | 50% |
| Nov 10, 2023 | Wedbush | maintain | Outperform → Outperform | $9 | 58% |
| Oct 23, 2023 | JMP Securities | downgrade | Market Outperform → Market Perform | $0 | 53% |
| Oct 19, 2023 | TD Cowen | downgrade | Outperform → Market Perform | $0 | 54% |
| Aug 16, 2023 | JP Morgan | maintain | Neutral → Neutral | $9 | 54% |
| Aug 3, 2023 | Needham | reiterate | — → Buy | $14 | 50% |
| Aug 3, 2023 | Wedbush | reiterate | Outperform → Outperform | $11 | 58% |
| May 11, 2023 | Needham | reiterate | Buy → Buy | $14 | 50% |
| Apr 19, 2023 | Needham | reiterate | — → Buy | $14 | 50% |
| Mar 24, 2023 | JMP Securities | reiterate | — → Market Outperform | $7 | 53% |
| Mar 23, 2023 | Needham | reiterate | — → Buy | $14 | 50% |
| Mar 6, 2023 | JMP Securities | maintain | — → Market Outperform | $2.23 | 53% |
| Feb 24, 2023 | Wedbush | maintain | Outperform → Outperform | $15 | 58% |
| Feb 24, 2023 | Needham | maintain | — → Buy | $14 | 50% |
| Jan 19, 2023 | JMP Securities | maintain | — → Market Outperform | $7 | 53% |
| Nov 8, 2022 | Canaccord Genuity | initiate | — → Buy | $9 | 48% |
| Aug 8, 2022 | JMP Securities | maintain | — → Market Outperform | $11 | 53% |
| Aug 5, 2022 | Needham | maintain | — → Buy | $23 | 50% |
| Dec 15, 2021 | JMP Securities | maintain | — → Market Outperform | $10 | 53% |
| Dec 15, 2021 | Needham | maintain | — → Buy | $27 | 50% |
| Dec 14, 2021 | Wedbush | maintain | Outperform → Outperform | $31 | 58% |
| Jul 14, 2021 | Wedbush | maintain | Outperform → Outperform | $36 | 58% |
| Jun 8, 2021 | JMP Securities | initiate | — → Market Outperform | $40 | 53% |
| Feb 24, 2021 | William Blair | initiate | — → Outperform | $45 | 48% |
| Feb 18, 2021 | Needham | initiate | — → Buy | $50 | 50% |
| Jul 7, 2020 | Wedbush | initiate | — → Outperform | $31 | 58% |
| Jul 7, 2020 | Cowen & Co. | initiate | — → Outperform | $0 | — |
| Jul 7, 2020 | JP Morgan | initiate | — → Overweight | $28 | 54% |
| Jul 7, 2020 | Jefferies | initiate | — → Buy | $38 | 52% |
Cross-Platform Signals
No cross-platform signals in the last 90 days